Specimen Procedures
Cheek Swab / Buccal Swab
DNA Analysis and Oral Microbiome Sampling
Overview
A cheek swab, also known as a buccal swab, is a non-invasive and painless method for collecting biological samples, primarily for DNA and microbiome analysis. This procedure involves gently rubbing the inside of a person's cheek with a specialized swab to collect buccal cells — epithelial cells shed from the lining of the mouth. These cells contain nuclear DNA, making them a suitable source for genetic testing. Additionally, the oral cavity harbors a diverse microbial community, and buccal swabs can also be used to sample this microbiome for research or diagnostic purposes.
The collection process is straightforward and can often be performed by individuals themselves. Typically, the patient rinses their mouth with water to remove any food particles, then firmly rubs a sterile swab against the inside of the cheek for 10–60 seconds. The process is usually repeated on the other cheek with a new swab to ensure an adequate sample. Unlike blood draws, it does not involve needles or any invasive techniques, making it an attractive option for individuals who are apprehensive about venipuncture, including children and the elderly.
Clinical Rationale
Cheek swabs are primarily utilized for genetic analysis, offering a non-invasive method to obtain DNA for a wide range of clinical applications. This includes diagnostic testing for inherited conditions — such as cystic fibrosis, Tay-Sachs disease, and other Mendelian disorders — by identifying specific genetic mutations or variations. They are also crucial in pharmacogenomics, where an individual's genetic makeup is analyzed to predict their response to certain medications, thereby optimizing drug dosages and minimizing adverse effects. Furthermore, buccal swabs are employed in carrier screening to identify individuals who carry a gene for a recessive disorder but do not express the disease themselves, which is vital for family planning and genetic counseling.
Beyond inherited conditions, buccal DNA can be used in susceptibility testing for complex diseases with a genetic component, such as certain cancers, cardiovascular diseases, and neurodegenerative disorders. Buccal swabs can also be used for microbiome sampling of the oral cavity, providing insights into oral health, systemic diseases linked to oral dysbiosis, and the overall microbial ecosystem.
Key Biomarkers
| Analyte | Clinical Application |
|---|---|
| Genomic DNA (gDNA) | Complete DNA set from buccal epithelial cells; used for all genetic analyses |
| Single Nucleotide Polymorphisms (SNPs) | Variations at single base pairs; used in pharmacogenomics, ancestry, and disease association studies |
| Specific Gene Mutations/Variants | CFTR (cystic fibrosis), HEXA (Tay-Sachs), BRCA1/2 (hereditary cancer risk) |
| Mitochondrial DNA (mtDNA) | Maternally inherited; used for maternal lineage tracing and forensic identification |
| Y-chromosome DNA (Y-DNA) | Paternally inherited; used for paternal lineage tracing and forensic investigations |
| Autosomal DNA | Non-sex chromosome DNA; used for general genetic analysis and ancestry |
| Oral Microbiota/Microbiome | Collective microbial genetic material in the oral cavity; associated with oral and systemic health |
| Bacterial DNA | Species-level identification of oral bacteria for microbiome studies |
| DNA Methylation Patterns | Epigenetic modifications influencing gene expression; studied in relation to disease risk |
| Pharmacogenomic Variants (CYP450 enzymes) | Drug metabolism gene variants; guide personalized medication selection and dosing |
Evidence Base
De Paolis et al. (2022) in the International Journal of Gynecologic Cancer demonstrated that buccal swabs are a valuable alternative source of DNA for BRCA1/2 next-generation sequencing evaluation, performing comparably to blood samples and supporting the use of buccal swabs to improve access to genetic testing for hereditary breast and ovarian cancer. Livy et al. (2011) in the Journal of Biomedicine and Biotechnology concluded that properly collected buccal DNA is suitable for high-throughput genotyping applications.
Walker et al. (1999) in Environmental Health Perspectives established buccal swabs as a viable and non-invasive method for DNA collection, facilitating large-scale genetic research and molecular epidemiologic studies. Zaura et al. (2021) in Periodontology 2000 emphasized the importance of standardized oral sample collection methods, including buccal swabs, for accurate and reproducible microbiota quantification in clinical studies. Liu et al. (2025) in Cancers highlighted the critical role of oral microbiome sampling in oral cancer research, discussing strategies for optimizing sample collection and enabling reliable translation into clinical applications.
Limitations and Caveats
Buccal swabs typically yield less DNA compared to blood samples, and the DNA can be more susceptible to degradation, particularly with improper collection or storage. Microbial contamination is another significant confounding factor — the oral cavity is home to a diverse microbiome, and bacterial DNA can be co-extracted with human DNA from buccal swabs. Pre-analytical variables such as recent food consumption, oral hygiene practices, and the collection technique itself can significantly influence sample quality.
While buccal swabs are excellent for assessing genetic predispositions or inherited conditions, they generally do not provide information about active disease states or immediate physiological changes that might be reflected in other biological samples like blood or urine. Genetic markers for disease susceptibility can be identified, but the test does not indicate whether the disease is currently active or its severity.
Clinical Note